Lamm, W., Kaufmann, H., Raderer, M., Hoffmann, M., Chott, A., Zielinski, C. and Drach, J. (2011) “Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma”, Haematologica. Pavia, Italy, 96(7), pp. 1008-1014. doi: 10.3324/haematol.2011.041392.